-
Mashup Score: 5
The optimal duration of antiplatelet therapy in high–bleeding risk (HBR) patients with coronary artery disease treated with newer-generation drug-elut…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
The optimal duration of antiplatelet therapy in high–bleeding risk (HBR) patients with coronary artery disease treated with newer-generation drug-elut…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
@Ortega_Paz @vlgmrc @PCRonline @EuroInterventio @escardio #ESCcongress #EAPCI Surprisingly a lot of EP studies For me: 1️⃣ #MasterDAPT https://t.co/J4VR9LY7MU 2️⃣ #STOPDAPT-2 ACS Single center patient selection https://t.co/IfIq7rpaJX 3️⃣ #Envisage-TAVI AF (although predictable) https://t.co/0vRuhxJkUm
-
#ESCCongress #MASTERDAPT by the one and only @vlgmrc @VranckxPascal To @Ortega_Paz: which primary EP? there are 3: (1) NACE) (2) MACCE (3) major or clinically relevant nonmajor bleeding (MCB) @CiticMexico @SOCiME_ @PCRonline @TCTMD @CRT_meeting https://t.co/xotGRSpbdN https://t.co/qPwdoyEq3v https://t.co/94BSBYAsQS